(MedPage Today) — FDA’s review of investigational drug for Duchenne muscular dystrophy signals deep skepticism
Uncategorized
VIDEO: Bulletproof blepharoplasty
At Hawaiian Eye, Andrew R. Harrison, MD, shares pearls on how to perform blepharoplasty and achieve positive aesthetic results and no complications, as well as maintaining patient satisfaction.
Uncategorized
RightEye Honored as Emerging Tech Company of the Year by Northern Virginia Chamber of Commerce
WASHINGTON–(BUSINESS WIRE)–RightEye LLC, a health technology company using eye tracking and gaming to revolutionize vision performance and patient care, was recognized last night as Emerging Tech Company of the Year at the 2016 Greater Washington Innovation Awards presented by the Northern Virginia Chamber of Commerce. “It’s an honor to be recognized as a leading technology innovator in the D.C. area, especially from among such a prestigious group of other inspiring companies,” said Barbara B
Under-expressed miR-9 gene may contribute to schizophrenia risk
By turning skin cells into brain neurons, researchers at the Icahn School of Medicine at Mount Sinai have identified that certain tiny molecules aiding in gene expression, known as microRNAs (miRNAs), are under-expressed in the brains of the 14 schizop…
Visual Field Needed for Driving Eligibility Preserved After Laser Panretinal Photocoagulation
Multispot laser panretinal photocoagulation (PRP) in proliferative diabetic retinopathy spares visual fields required for driving eligibility, researchers report. Reuters Health Information
Uncategorized
Abbott reports $4.9 billion in worldwide sales in first quarter
Abbott reported $4.9 billion in worldwide sales in the first quarter, a 5.1% increase on an operational basis and a 0.2% decrease on a reported basis compared with the previous year, according to a press release. U.S. sales increased 1.9%, partly becau…